1型糖尿病技术使用下严重低血糖与低血糖感知受损的持续负担:随访调查
该研究对美国1型糖尿病成人队列约2年后随访,评估血糖指标、严重低血糖事件(SHE)、低血糖感知受损(IAH)及技术使用变化。随访时CGM使用达94.4%,AID使用增加17.7%,HbA1c<7%者67.4%,但IAH约30%、SHE约20%持续存在,提示技术使用未完全消除严重低血糖风险。
要点
- 随访时CGM使用94.4%,AID使用增加17.7%,但HbA1c达标率仅67.4%。
- IAH约30%、SHE约20%在基线和随访中均保持高位。
- 仅靠CGM和AID未能消除严重低血糖风险,血糖管理仍不理想。
核心结论
- 尽管多数参与者使用CGM且AID使用增加,约三分之一未达HbA1c目标,约20%过去一年仍有SHE,约30%存在IAH。
- CGM和AID是重要进步,但单独使用未减轻严重低血糖风险,血糖管理仍欠佳。
研究设计与样本
- 对原始回顾性观察研究参与者约2年后进行横断面随访调查。
- 共1056名1型糖尿病成人纳入分析,应答率53%,平均年龄46岁,平均病程29年,71%女性,97%白人。
主要发现
- CGM使用率从原始研究的91.8%升至随访的94.4%,AID使用增加17.7%。
- HbA1c<7%的比例从原始研究的61.7%升至随访的67.4%。
- IAH和SHE比例在两项研究中均保持约30%和约20%的高位。
临床怎么用
- 对使用CGM和AID的1型糖尿病患者仍需常规评估IAH和SHE,不能仅依赖技术设备。
- 约三分之一患者HbA1c未达标,需强化血糖管理教育及个体化治疗调整。
局限性
- 横断面随访设计,变化评估基于自我报告数据。
- 样本以女性、白人为主,代表性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess longitudinal trends in glycemic metrics, prevalence of severe hypoglycemic events (SHEs), impaired awareness of hypoglycemia (IAH), and technology use (continuous glucose monitoring [CGM], automated insulin delivery [AID]) in a real-world U.S. cohort of adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: This was a cross-sectional study of adults with type 1 diabetes conducted ∼2 years after participants enrolled in the original retrospective observational study. Participants self-reported technology use, insulin delivery method, glycated hemoglobin (HbA1c), IAH, and SHEs. Change was assessed among these variables from the initial and follow-up study. RESULTS: Approximately 2 years after the original survey, 1,056 adults responded to the follow-up survey and were eligible for analysis (53% response rate; mean [SD] age: 46 [16] years; mean [SD] type 1 diabetes duration: 29 [16] years; 71% female; 97% White). Most reported using CGM in the original study (91.8%) and at follow-up (94.4%), while the use of AID increased 17.7%. In the original study, 61.7% reported HbA1c <7% vs. 67.4% at follow-up. Proportions of individuals with IAH and SHEs remained high at ∼30% and ∼20%, respectively, in both studies. CONCLUSIONS: Although most participants used CGM and the use of AID increased, approximately one-third of respondents did not achieve HbA1c targets, ∼20% continued to have SHEs in the last year, and ∼30% had IAH. This highlights that while CGM and AID systems are a significant advancement, their use alone has not mitigated the risk of severe hypoglycemia, and glucose management still remains suboptimal.
引用
- Sherr JL, Molinsky RL, Pakalapati T, et al. Persistent Burden of Severe Hypoglycemia and Impaired Awareness of Hypoglycemia Among People With Type 1 Diabetes Despite Technology Use: A Follow-up Survey. Diabetes Care. 2026. PMID: 41747141. doi:10.2337/dc25-2345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。